S. Gallardo

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients

Travis L. Rice-Stitt, M. Deavers, R. Freedman, 2008, Cancer Immunology, Immunotherapy.

Migration deficit in monocyte-macrophages in human ovarian cancer

F. Marincola, E. Wang, D. Stroncek, 2008, Cancer Immunology, Immunotherapy.

Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

R. Iyer, S. Apte, P. Ramirez, 2006, Journal of Translational Medicine.

rIFN-γ-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition

B. Melichar, Wei Hu, R. Freedman, 2003, Journal of Translational Medicine.

Journal of Translational Medicine Rifn-γ-mediated Growth Suppression of Platinum-sensitive and -resistant Ovarian Tumor Cell Lines Not Dependent upon Arginase Inhibition Interferon-gammaarginaseovarian Neoplasms

B. Melichar, Wei Hu, R. Freedman, 2022 .

Hemapoietic, immunomodulatory, antitumor, and toxicity profiles of sequential GM-CSF and IFNγ1b biotherapy and carboplatin in recurrent ovarian carcinoma

R. Iyer, Y. Yang, S. Apte, 2005 .

Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines.

B. Melichar, Wei Hu, R. Freedman, 2007, Gynecologic oncology.